These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 29475902)
1. DI Staso S; Agnifili L; Cecannecchia S; DI Gregorio A; Ciancaglini M In Vivo; 2018; 32(2):211-220. PubMed ID: 29475902 [TBL] [Abstract][Full Text] [Related]
2. The use of benzalkonium chloride in topical glaucoma treatment: An investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells. Nagstrup AH Acta Ophthalmol; 2023 Dec; 101 Suppl 278():3-21. PubMed ID: 38037546 [TBL] [Abstract][Full Text] [Related]
3. Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study. Agnifili L; Mastropasqua R; Fasanella V; Brescia L; Scatena B; Oddone F; Mastropasqua L J Glaucoma; 2018 Apr; 27(4):364-370. PubMed ID: 29401160 [TBL] [Abstract][Full Text] [Related]
5. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study. Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975 [TBL] [Abstract][Full Text] [Related]
6. The Effect of Prostaglandin Analogs on Central Corneal Thickness of Patients with Glaucoma or Ocular Hypertension: A Systematic Review. Lu Y; Zhong E; Wu J; Cao Y Ophthalmic Res; 2023; 66(1):431-444. PubMed ID: 36455536 [TBL] [Abstract][Full Text] [Related]
7. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions. Liang H; Brignole-Baudouin F; Riancho L; Baudouin C Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057 [TBL] [Abstract][Full Text] [Related]
8. Trans-conjunctival aqueous humor outflow in glaucomatous patients treated with prostaglandin analogues: an in vivo confocal microscopy study. Mastropasqua R; Fasanella V; Pedrotti E; Lanzini M; Di Staso S; Mastropasqua L; Agnifili L Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1469-76. PubMed ID: 24867312 [TBL] [Abstract][Full Text] [Related]
9. In vivo confocal microscopy of meibomian glands in glaucoma. Agnifili L; Fasanella V; Costagliola C; Ciabattoni C; Mastropasqua R; Frezzotti P; Mastropasqua L Br J Ophthalmol; 2013 Mar; 97(3):343-9. PubMed ID: 23269683 [TBL] [Abstract][Full Text] [Related]
10. In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study. Kim JH; Kim EJ; Kim YH; Kim YI; Lee SH; Jung JC; Lee KW; Park YJ Korean J Ophthalmol; 2015 Aug; 29(4):270-9. PubMed ID: 26240512 [TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension. Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma. Kim JS; Blizzard S; Woodward JA; Leyngold IM; Liss J; Freedman SF Ophthalmol Glaucoma; 2020; 3(4):288-294. PubMed ID: 33008561 [TBL] [Abstract][Full Text] [Related]
13. Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors. Lusthaus JA; Goldberg I Expert Opin Emerg Drugs; 2016; 21(1):117-28. PubMed ID: 26854598 [TBL] [Abstract][Full Text] [Related]
14. The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction. Mocan MC; Uzunosmanoglu E; Kocabeyoglu S; Karakaya J; Irkec M J Glaucoma; 2016 Sep; 25(9):770-4. PubMed ID: 27513901 [TBL] [Abstract][Full Text] [Related]
15. In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma. Frezzotti P; Fogagnolo P; Haka G; Motolese I; Iester M; Bagaglia SA; Mittica P; Menicacci C; Rossetti L; Motolese E Acta Ophthalmol; 2014 Mar; 92(2):e133-40. PubMed ID: 24020826 [TBL] [Abstract][Full Text] [Related]
16. In vitro effects of preservative-free and preserved prostaglandin analogs on primary cultured human conjunctival fibroblast cells. Kim EJ; Kim YH; Kang SH; Lee KW; Park YJ Korean J Ophthalmol; 2013 Dec; 27(6):446-53. PubMed ID: 24311931 [TBL] [Abstract][Full Text] [Related]
17. Medical therapy for glaucoma: what to add after a prostaglandin analogs? Tanna AP; Lin AB Curr Opin Ophthalmol; 2015 Mar; 26(2):116-20. PubMed ID: 25594765 [TBL] [Abstract][Full Text] [Related]
18. DI Staso S; Agnifili L; Ciancaglini M; Murano G; Borrelli E; Mastropasqua L In Vivo; 2018; 32(2):437-443. PubMed ID: 29475934 [TBL] [Abstract][Full Text] [Related]
19. Effect of preservative-free and preserved prostaglandin analogues on the histology of cornea of adult male guinea pigs following repeated exposure. Ali AF; Salama RM; Soliman MA Folia Morphol (Warsz); 2022; 81(1):52-64. PubMed ID: 33438192 [TBL] [Abstract][Full Text] [Related]
20. Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment. Tiedemann D; Mouhammad ZA; Utheim TP; Dartt DA; Heegaard S; Petrovski G; Kolko M J Glaucoma; 2019 Apr; 28(4):325-333. PubMed ID: 30585937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]